CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

Clinical trial NCT07179692 · RECRUITING

Trial details

NCT number: NCT07179692
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Gastric Cancer Colon Cancer Rectal Cancer Esophageal Cancer Pancreas Cancer

Start date: 2025-09-12
Primary completion: 2028-03-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.